Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02039726
Title	(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Recruitment	Completed
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Daiichi Sankyo Inc.
Indications	acute myeloid leukemia
Therapies	Cytarabine + Fludarabine Cytarabine + Etoposide + Mitoxantrone Quizartinib Filgrastim + Idarubicin
Age Groups:	senior \| adult
Covered Countries	USA \| POL \| NLD \| ITA \| HUN \| HRV \| GBR \| FRA \| ESP \| DEU \| CZE \| CAN \| BEL \| AUS